ArticlePloS one2021

Immunoglobulin Replacement Therapy is critical and cost-effective in increasing life expectancy and quality of life in patients suffering from Common Variable Immunodeficiency Disorders (CVID): A health-economic assessment.

Philippe van Wilder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.